PA8825401A1 - SYSTEMS AND METHODS TO SELECT FLOUR - Google Patents

SYSTEMS AND METHODS TO SELECT FLOUR

Info

Publication number
PA8825401A1
PA8825401A1 PA20098825401A PA8825401A PA8825401A1 PA 8825401 A1 PA8825401 A1 PA 8825401A1 PA 20098825401 A PA20098825401 A PA 20098825401A PA 8825401 A PA8825401 A PA 8825401A PA 8825401 A1 PA8825401 A1 PA 8825401A1
Authority
PA
Panama
Prior art keywords
compounds
systems
methods
formula
invention refers
Prior art date
Application number
PA20098825401A
Other languages
Spanish (es)
Inventor
Upreti Praveen
Jalali Rohit
E Grieshober William Jr
S Roberts John
D Haller Melissa
Fuchs Michael
Ilyin Ilya
Original Assignee
Rich Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rich Products Corp filed Critical Rich Products Corp
Publication of PA8825401A1 publication Critical patent/PA8825401A1/en

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA I, EN LA QUE A, Y, Z, R3 A R6, R20 A R22 Y R50 TIENEN LOS SIGNIFICADOS QUE SE INDICAN EN LAS REIVINDICACIONES, QUE SON VALIOSOS COMPUESTOS ACTIVOS FARMACEUTICOS. ESPECIFICAMENTE, SON INHIBIDORES DEL RECEPTOR DEL GEN DE DIFERENCIACION ENDOTELIAL 2 (EDG-2, EDG2), QUE ES ACTIVADO POR ACIDO LISOFOSFATIDICO (LPA) Y TAMBIEN SE DENOMINA RECEPTOR LPA1, Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES TALES COMO ATEROSCLEROSIS, INFARTO DE MIOCARDIO E INSUFICIENCIA CARDIACA, POR EJEMPLO. LA INVENCION SE REFIERE ADEMAS A PROCEDIMIENTOS PARA PREPARAR LOS COMPUESTOS DE LA FORMULA I, A SU USO Y A COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN.THE PRESENT INVENTION REFERS TO COMPOUNDS OF FORMULA I, IN WHICH A, AND, Z, R3 TO R6, R20 TO R22 AND R50 HAVE THE MEANINGS THAT ARE INDICATED IN THE CLAIMS, WHICH ARE VALUABLE ACTIVE PHARMACEUTICAL COMPOUNDS. SPECIFICALLY, THEY ARE INHIBITORS OF THE RECEIVER OF THE ENDOTELIAL DIFFERENTIATION GEN 2 (EDG-2, EDG2), WHICH IS ACTIVATED BY LYSOPHOSPHYTIDIC ACID (LPA) AND ALSO IS NAME RECEIVER LPA1, AND ARE USEFUL FOR THE TREATMENT OF INFANT DISEASES, CARDIAC MIOCARDIO AND INSUFFICIENCY, FOR EXAMPLE. THE INVENTION REFERS IN ADDITION TO PROCEDURES TO PREPARE THE COMPOUNDS OF FORMULA I, ITS USE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.

PA20098825401A 2008-05-02 2009-05-04 SYSTEMS AND METHODS TO SELECT FLOUR PA8825401A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5009108P 2008-05-02 2008-05-02

Publications (1)

Publication Number Publication Date
PA8825401A1 true PA8825401A1 (en) 2009-12-16

Family

ID=41255469

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20098825401A PA8825401A1 (en) 2008-05-02 2009-05-04 SYSTEMS AND METHODS TO SELECT FLOUR

Country Status (5)

Country Link
AR (1) AR071626A1 (en)
NL (1) NL2002837C (en)
PA (1) PA8825401A1 (en)
TW (1) TW201032153A (en)
WO (1) WO2009135216A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906851A (en) * 1997-03-19 1999-05-25 Smith; Frank D. Process for improving baking properties of flour
WO2001095219A1 (en) * 2000-06-05 2001-12-13 Ag-Chem Equipment Company, Inc. System and method for providing profit analysis for site-specific farming
ATE439767T1 (en) * 2002-04-02 2009-09-15 Moffat Pty Ltd METHOD FOR PLANNING A PRODUCTION SERIES OF BAKERY PRODUCTS
US20040019434A1 (en) * 2002-07-17 2004-01-29 Cornell Research Foundation, Inc. Method and system for individual cattlem management
US7829128B2 (en) * 2006-06-30 2010-11-09 Kraft Foods Global Brands Llc Production of whole grain-containing composite food products

Also Published As

Publication number Publication date
TW201032153A (en) 2010-09-01
WO2009135216A1 (en) 2009-11-05
NL2002837C (en) 2010-04-14
AR071626A1 (en) 2010-06-30
NL2002837A1 (en) 2009-11-03

Similar Documents

Publication Publication Date Title
SV2010003717A (en) CONDENSED CYCLOPENTANOCARBOXYLIC ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS
UY39630A (en) BROMODOMAIN INHIBITORS
CR20120203A (en) DERIVATIVES OF CYCLIC CARBOXYLIC ACID SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS
DOP2015000308A (en) BROMODOMINIUM INHIBITORS
MA34069B1 (en) N- (IMIDAZOPYRIMIDIN-7-YL) HETEROARYLAMIDE DERIVATIVES AND THEIR USE AS PDE10A INHIBITORS)
EA201171066A1 (en) NEW SUBSTITUTED DERIVATIVES OF BENZOXIAZOLE, BENZIMIDAZOLE, OXAZOZOLOPIRIDINE AND IMIDAZOPIRIDINE AS GAMMA SECRETIS MODULATORS
DOP2012000243A (en) FUSIONED TRICYCLIC SILILO COMPOUNDS AND USE OF THE SAME IN THE MANUFACTURE OF USEFUL DRUGS IN THE TREATMENT OF VIRAL DISEASES
ECSP14006132A (en) BENZOTHIAZOLE-6-IL ACETIC ACID DERIVATIVES AND THEIR USE TO TREAT HIV INFECTION
BR112012023421A2 (en) pharmaceutical composition for intraocular pressure increase treatment
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
CR20130432A (en) 1,3-OXAZINES AS INHIBITORS OF THE BACE1 AND / OR THE BACE2
CO6700831A2 (en) Pyrazine derivatives as enac blockers
UA110310C2 (en) Compounds n-aryl triazole as antagonists receptors lisophosphatidic acid (lpar)
EA201201343A1 (en) DERIVATIVES OF 4-AMINOPYRIMIDINE AND THEIR ACTING MATTER AS ANTAGONISTS OF ADENOSIN RECEPTOR A
CO6690816A2 (en) Quinazolin-4 (3h) -one derivatives used as inhibitors of pi3 kinase
MX2013008431A (en) Mineralocorticoid receptor antagonists.
EA201270492A1 (en) COMPOUNDS FOR THE TREATMENT OF DISLIPIDEMIC AND RELATED DISEASES
EA201500298A1 (en) ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES
MA34094B1 (en) 3- (HETEROARYLAMINO) -1,2,3,4-TETRAHYDRO-9H-CARBAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF THE PROSTAGLANDIN D2 RECEPTOR
EA201492097A1 (en) 5-AMINO [1,4] TIAZINS AS BETA SECRETASE INHIBITORS 1
DOP2010000232A (en) INDAZOL DERIVATIVES
MX341577B (en) Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors.
MX2011013869A (en) Anthelmintic agents and their use.
MX342859B (en) Tamarind seed polysaccharide for use in the treatment of inflammatory diseases.
EA201491651A1 (en) NEW CONNECTIONS FOR THE TREATMENT OF DISLIPIDEMIA AND RELATED DISEASES